Risk factors and management of hyperuricemia after renal transplantation

HIGHLIGHTS

  • who: Xiaoyu Zi and colleagues from the (UNIVERSITY) have published the research: Risk factors and management of hyperuricemia after renal transplantation, in the Journal: (JOURNAL) of 06/01/2023
  • what: Calcineurin is a significant target of immunosuppressive therapy with the main aim of inhibiting T-cell proliferative responses to donor alloantigens . It was reported that an interaction between azathioprine and allopurinol inhibiting the XO pathway of azathioprine metabolism, was the main reason for severe anemia .
  • future: Studies are still needed to confirm a bidirectional link between HUA and hypertension. Studies are needed to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?